Gland Pharma posts Q1 FY24 consolidated PAT at Rs. 194.10 Cr
News

Gland Pharma posts Q1 FY24 consolidated PAT at Rs. 194.10 Cr

Gland Pharma has reported total income of Rs. 1246.23 crores during the period ended June 30, 2023

  • By IPP Bureau | August 08, 2023

Gland Pharma Limited has reported Consolidated financial results for the period ended June 30, 2023.

Gland Pharma has posted net profit of Rs. 194.10 crores for the period ended June 30, 2023 as against net profit of Rs. 78.68 crores for the period ended March 31, 2023. The company posted net profit of Rs.229.16 crores for the period ended June 30, 2022.

Gland Pharma has reported total income of Rs. 1246.23 crores during the period ended June 30, 2023 as compared to Rs. 823.95 crores during the period ended March 31, 2023. The company reported total income of Rs.931.28 crores during the period ended June 30, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization